“…However, recent observations from five independent studies in human patients have linked mutations in all four AP-4 subunits (µ1; AP4M1(SPG50), β1; AP4B1(SPG47), ε1; AP4E1(SPG51), and σ1; AP4S1(SPG52)) to progressive Spastic Paraplegia, a disease characterized by a complex phenotype that manifests in infancy or early childhood [22,62,68,69]. Core clinical features include hypotonia, cognitive and motor delays, seizures, facial dimorphism, stereotypic laughter with tongue protrusion, and thinning of the corpus callosum [68,70]. In fact, the phenotype is robust enough to be considered a clinically recognizable "AP-4 deficiency syndrome."…”